Loading…

Antifungal Susceptibility Testing of Fusarium: A Practical Approach

In vitro susceptibility testing of is becoming increasingly important because of frequency and diversity of infections and because resistance profiles are species-specific. Reference methods for antifungal susceptibility testing (AFST) are those of Clinical and Laboratory Standards Institute (CLSI)...

Full description

Saved in:
Bibliographic Details
Published in:Journal of fungi (Basel) 2017-04, Vol.3 (2), p.19
Main Authors: Al-Hatmi, Abdullah M S, Curfs-Breuker, Ilse, de Hoog, G Sybren, Meis, Jacques F, Verweij, Paul E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c538t-c07716e4c96e3db941a77c9568cad488e502f7ed9b479704af470f2f7c57484b3
cites cdi_FETCH-LOGICAL-c538t-c07716e4c96e3db941a77c9568cad488e502f7ed9b479704af470f2f7c57484b3
container_end_page
container_issue 2
container_start_page 19
container_title Journal of fungi (Basel)
container_volume 3
creator Al-Hatmi, Abdullah M S
Curfs-Breuker, Ilse
de Hoog, G Sybren
Meis, Jacques F
Verweij, Paul E
description In vitro susceptibility testing of is becoming increasingly important because of frequency and diversity of infections and because resistance profiles are species-specific. Reference methods for antifungal susceptibility testing (AFST) are those of Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility (EUCAST), but breakpoints (BPs) have not yet been established. One of the problems is that phylogenetic distances between species are much smaller than between species of, e.g., . Epidemiological cutoff values (ECVs) for some species have been determined in order to differentiate wild-type from non-wild-type isolates. In clinical routine, commercially available assays such as Etest, Sensititre or others provide essential agreement with reference methods. Our objective is to summarize antifungal susceptibility testing of genus in the clinical laboratory: how to do it, when to do it, and how to interpret it.
doi_str_mv 10.3390/jof3020019
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_97c32096b06c4001b7874edcc40f471d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_97c32096b06c4001b7874edcc40f471d</doaj_id><sourcerecordid>1992009503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-c07716e4c96e3db941a77c9568cad488e502f7ed9b479704af470f2f7c57484b3</originalsourceid><addsrcrecordid>eNpdkV9rFDEUxYMottS--AFkwBcRVm_-TDLXB2FZbC0UFKzgW8hkMtsss5MxmRH67b11a219SnLvj8PJOYy95PBOSoT3u9RLEAAcn7BjIQFXGpofTx_cj9hpKTsgpG40onzOjgRKw2tpjtlmPc6xX8atG6pvS_FhmmMbhzjfVFehzHHcVqmvzpbiclz2H6p19TU7P0dP_HqacnL--gV71ruhhNO784R9P_t0tfm8uvxyfrFZX658LZt55cEYroPyqIPsWlTcGeOx1o13nWqaUIPoTeiwVQYNKNcrAz2NfG1Uo1p5wi4Oul1yOzvluHf5xiYX7Z9BylvrMlkbgkXjpQDULWiv6OetaYwKnacHqfKOtD4etKal3dMijHN2wyPRx5sxXttt-mVrCg6FIIE3dwI5_VwoKruPFN8wuDGkpViOSK1gDZLQ1_-hu7TkkaKyggulDUcNRL09UD6nUnLo781wsLdV239VE_zqof179G-x8jfq7KK8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2124671960</pqid></control><display><type>article</type><title>Antifungal Susceptibility Testing of Fusarium: A Practical Approach</title><source>Publicly Available Content Database</source><source>IngentaConnect Journals</source><source>PubMed Central</source><creator>Al-Hatmi, Abdullah M S ; Curfs-Breuker, Ilse ; de Hoog, G Sybren ; Meis, Jacques F ; Verweij, Paul E</creator><creatorcontrib>Al-Hatmi, Abdullah M S ; Curfs-Breuker, Ilse ; de Hoog, G Sybren ; Meis, Jacques F ; Verweij, Paul E</creatorcontrib><description>In vitro susceptibility testing of is becoming increasingly important because of frequency and diversity of infections and because resistance profiles are species-specific. Reference methods for antifungal susceptibility testing (AFST) are those of Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility (EUCAST), but breakpoints (BPs) have not yet been established. One of the problems is that phylogenetic distances between species are much smaller than between species of, e.g., . Epidemiological cutoff values (ECVs) for some species have been determined in order to differentiate wild-type from non-wild-type isolates. In clinical routine, commercially available assays such as Etest, Sensititre or others provide essential agreement with reference methods. Our objective is to summarize antifungal susceptibility testing of genus in the clinical laboratory: how to do it, when to do it, and how to interpret it.</description><identifier>ISSN: 2309-608X</identifier><identifier>EISSN: 2309-608X</identifier><identifier>DOI: 10.3390/jof3020019</identifier><identifier>PMID: 29371537</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Breakpoints ; clinical laboratory ; CLSI ; Epidemiology ; Etest ; EUCAST ; Fungi ; Fusarium ; Hospitals ; Identification ; Infections ; Infectious diseases ; Laboratories ; Methods ; Morphology ; Peptides ; Phylogeny ; Proteins ; Review ; RNA polymerase ; Species ; Substance abuse treatment ; susceptibility test</subject><ispartof>Journal of fungi (Basel), 2017-04, Vol.3 (2), p.19</ispartof><rights>2017. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 by the authors. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-c07716e4c96e3db941a77c9568cad488e502f7ed9b479704af470f2f7c57484b3</citedby><cites>FETCH-LOGICAL-c538t-c07716e4c96e3db941a77c9568cad488e502f7ed9b479704af470f2f7c57484b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2124671960/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2124671960?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29371537$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Hatmi, Abdullah M S</creatorcontrib><creatorcontrib>Curfs-Breuker, Ilse</creatorcontrib><creatorcontrib>de Hoog, G Sybren</creatorcontrib><creatorcontrib>Meis, Jacques F</creatorcontrib><creatorcontrib>Verweij, Paul E</creatorcontrib><title>Antifungal Susceptibility Testing of Fusarium: A Practical Approach</title><title>Journal of fungi (Basel)</title><addtitle>J Fungi (Basel)</addtitle><description>In vitro susceptibility testing of is becoming increasingly important because of frequency and diversity of infections and because resistance profiles are species-specific. Reference methods for antifungal susceptibility testing (AFST) are those of Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility (EUCAST), but breakpoints (BPs) have not yet been established. One of the problems is that phylogenetic distances between species are much smaller than between species of, e.g., . Epidemiological cutoff values (ECVs) for some species have been determined in order to differentiate wild-type from non-wild-type isolates. In clinical routine, commercially available assays such as Etest, Sensititre or others provide essential agreement with reference methods. Our objective is to summarize antifungal susceptibility testing of genus in the clinical laboratory: how to do it, when to do it, and how to interpret it.</description><subject>Breakpoints</subject><subject>clinical laboratory</subject><subject>CLSI</subject><subject>Epidemiology</subject><subject>Etest</subject><subject>EUCAST</subject><subject>Fungi</subject><subject>Fusarium</subject><subject>Hospitals</subject><subject>Identification</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Laboratories</subject><subject>Methods</subject><subject>Morphology</subject><subject>Peptides</subject><subject>Phylogeny</subject><subject>Proteins</subject><subject>Review</subject><subject>RNA polymerase</subject><subject>Species</subject><subject>Substance abuse treatment</subject><subject>susceptibility test</subject><issn>2309-608X</issn><issn>2309-608X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkV9rFDEUxYMottS--AFkwBcRVm_-TDLXB2FZbC0UFKzgW8hkMtsss5MxmRH67b11a219SnLvj8PJOYy95PBOSoT3u9RLEAAcn7BjIQFXGpofTx_cj9hpKTsgpG40onzOjgRKw2tpjtlmPc6xX8atG6pvS_FhmmMbhzjfVFehzHHcVqmvzpbiclz2H6p19TU7P0dP_HqacnL--gV71ruhhNO784R9P_t0tfm8uvxyfrFZX658LZt55cEYroPyqIPsWlTcGeOx1o13nWqaUIPoTeiwVQYNKNcrAz2NfG1Uo1p5wi4Oul1yOzvluHf5xiYX7Z9BylvrMlkbgkXjpQDULWiv6OetaYwKnacHqfKOtD4etKal3dMijHN2wyPRx5sxXttt-mVrCg6FIIE3dwI5_VwoKruPFN8wuDGkpViOSK1gDZLQ1_-hu7TkkaKyggulDUcNRL09UD6nUnLo781wsLdV239VE_zqof179G-x8jfq7KK8</recordid><startdate>20170426</startdate><enddate>20170426</enddate><creator>Al-Hatmi, Abdullah M S</creator><creator>Curfs-Breuker, Ilse</creator><creator>de Hoog, G Sybren</creator><creator>Meis, Jacques F</creator><creator>Verweij, Paul E</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170426</creationdate><title>Antifungal Susceptibility Testing of Fusarium: A Practical Approach</title><author>Al-Hatmi, Abdullah M S ; Curfs-Breuker, Ilse ; de Hoog, G Sybren ; Meis, Jacques F ; Verweij, Paul E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-c07716e4c96e3db941a77c9568cad488e502f7ed9b479704af470f2f7c57484b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Breakpoints</topic><topic>clinical laboratory</topic><topic>CLSI</topic><topic>Epidemiology</topic><topic>Etest</topic><topic>EUCAST</topic><topic>Fungi</topic><topic>Fusarium</topic><topic>Hospitals</topic><topic>Identification</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Laboratories</topic><topic>Methods</topic><topic>Morphology</topic><topic>Peptides</topic><topic>Phylogeny</topic><topic>Proteins</topic><topic>Review</topic><topic>RNA polymerase</topic><topic>Species</topic><topic>Substance abuse treatment</topic><topic>susceptibility test</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Hatmi, Abdullah M S</creatorcontrib><creatorcontrib>Curfs-Breuker, Ilse</creatorcontrib><creatorcontrib>de Hoog, G Sybren</creatorcontrib><creatorcontrib>Meis, Jacques F</creatorcontrib><creatorcontrib>Verweij, Paul E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Journal of fungi (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Hatmi, Abdullah M S</au><au>Curfs-Breuker, Ilse</au><au>de Hoog, G Sybren</au><au>Meis, Jacques F</au><au>Verweij, Paul E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antifungal Susceptibility Testing of Fusarium: A Practical Approach</atitle><jtitle>Journal of fungi (Basel)</jtitle><addtitle>J Fungi (Basel)</addtitle><date>2017-04-26</date><risdate>2017</risdate><volume>3</volume><issue>2</issue><spage>19</spage><pages>19-</pages><issn>2309-608X</issn><eissn>2309-608X</eissn><abstract>In vitro susceptibility testing of is becoming increasingly important because of frequency and diversity of infections and because resistance profiles are species-specific. Reference methods for antifungal susceptibility testing (AFST) are those of Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility (EUCAST), but breakpoints (BPs) have not yet been established. One of the problems is that phylogenetic distances between species are much smaller than between species of, e.g., . Epidemiological cutoff values (ECVs) for some species have been determined in order to differentiate wild-type from non-wild-type isolates. In clinical routine, commercially available assays such as Etest, Sensititre or others provide essential agreement with reference methods. Our objective is to summarize antifungal susceptibility testing of genus in the clinical laboratory: how to do it, when to do it, and how to interpret it.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>29371537</pmid><doi>10.3390/jof3020019</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2309-608X
ispartof Journal of fungi (Basel), 2017-04, Vol.3 (2), p.19
issn 2309-608X
2309-608X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_97c32096b06c4001b7874edcc40f471d
source Publicly Available Content Database; IngentaConnect Journals; PubMed Central
subjects Breakpoints
clinical laboratory
CLSI
Epidemiology
Etest
EUCAST
Fungi
Fusarium
Hospitals
Identification
Infections
Infectious diseases
Laboratories
Methods
Morphology
Peptides
Phylogeny
Proteins
Review
RNA polymerase
Species
Substance abuse treatment
susceptibility test
title Antifungal Susceptibility Testing of Fusarium: A Practical Approach
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A43%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antifungal%20Susceptibility%20Testing%20of%20Fusarium:%20A%20Practical%20Approach&rft.jtitle=Journal%20of%20fungi%20(Basel)&rft.au=Al-Hatmi,%20Abdullah%20M%20S&rft.date=2017-04-26&rft.volume=3&rft.issue=2&rft.spage=19&rft.pages=19-&rft.issn=2309-608X&rft.eissn=2309-608X&rft_id=info:doi/10.3390/jof3020019&rft_dat=%3Cproquest_doaj_%3E1992009503%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c538t-c07716e4c96e3db941a77c9568cad488e502f7ed9b479704af470f2f7c57484b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2124671960&rft_id=info:pmid/29371537&rfr_iscdi=true